The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: AIM giant ASOS to move to London Main Market

Thu, 13th Jan 2022 08:24

(Alliance News) - Online fashion retailer ASOS said Thursday it plans to move to the London Main Market from AIM.

ASOS has dominated the junior market for the past 20 years as its largest, or one of its largest, stocks, with a market capitalisation of GBP2.45 billion.

"ASOS directors believe that given ASOS's size and scale, now is the appropriate time to move from AIM to a premium Main Market listing," the company said, explaining it thinks the move will raise its corporate profile and recognition, and increase investment in its shares by global institutions.

The company said it will move its listing by the end of February. JP Morgan will act as sponsor for the Main Market admission, which won't involve any fund raise.

In conjunction with the shift, ASOS has hired Patrick Kennedy as senior independent director. Kennedy, the former chief executive of Irish betting firm Paddy Power - now Flutter Entertainment - is the chair of Bank of Ireland Group.

ASOS also provided a trading update for the last four months of 2021.

Total revenue rose by 2% to GBP1.39 billion from GBP1.36 billion a year before. In constant currency, the increase was 5%. UK sales rose by 13%, while EU sales rose by 2% and US sales by 11%, both at constant currency. However, Rest of World sales fell by 15% at constant currency and by 20% at actual rates.

Gross margin narrowed by 400 basis points to 43.0%, as expected, ASOS said, due to clearance activity. The product returns rate has normalised in line with expectations.

ASOS said it full-year guidance remains unchanged at 10% to 15% revenue growth and adjusted pretax profit of GBP110 million to GBP140 million.

"Our listing on AIM for the past 20 years has been an important part of ASOS's development, but the time is now right to move to the Main Market as we focus on delivering our medium-term guidance and longer-term growth ambitions," said Chief Operating Officer Mat Dunn.

ASOS shares were up 8.5% at 2,450.00 pence.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: down 0.2% at 7,536.86

----------

Hang Seng: up 0.1% at 24,429.77

Nikkei 225: closed down 1.0% at 28,489.13

S&P/ASX 200: closed up 0.5% at 7,474.40

----------

DJIA: closed up 38.30 points, 0.1%, at 36,290.32

S&P 500: closed up 0.3% at 4,726.35

Nasdaq Composite: closed up 0.2% at 15,188.39

----------

EUR: up at USD1.1463 (USD1.1425)

GBP: up at USD1.3730 ((USD1.3693)

USD: down at JPY114.50 (JPY114.73)

Gold: up at USD1,826.88 per ounce (USD1,822.60)

Oil (Brent): down at USD84.24 a barrel (USD84.68)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Thursday's key economic events still to come

0930 GMT UK BoE quarterly bank liabilities survey

1030 EST US EIA weekly natural gas storage report

0830 EST US producer price index

0830 EST US initial jobless claims

----------

A second consecutive day of almost unilaterally negative coverage by the press of UK Prime Minister Boris Johnson features widespread calls for his resignation after his apology during Prime Minister's Questions. Johnson admitted at the beginning of PMQs he attended a lockdown party in the No 10 garden on 20 May, 2020. He offered an apology but said he thought it classified as a work event and therefore would fall within the rules. In response to repeated calls to resign from members of opposition parties, including Labour Leader Keir Starmer, Johnson asked an official inquiry be allowed to "establish the facts". Much of Thursday's media coverage focused on growing discontent within the PM's own party. The Guardian says his future is on a 'knife's-edge', with some Conservative MPs openly calling for his resignation while others speak off-the-record.

----------

BROKER RATING CHANGES

----------

Jefferies raises Mears Group to 'Buy' (Hold) - price target 275 (210) pence

----------

BofA cuts IAG to 'Neutral' (Buy) - price target 180 (240) pence

----------

Morgan Stanley resumes Smiths Group with 'Equal-Weight' - target 1,580 pence

----------

COMPANIES - FTSE 100

----------

Tesco, the UK's largest supermarket chain, said it delivered a strong third quarter and Christmas trading performance, bolstered by the grocer's "unwavering" commitment to value for customers. For the 19 weeks to January 8, like-for-like retail sales were up 2.6% compared to the same period the year before. Over the Christmas period alone, like-for-like sales grew 3.2% year-on-year. Tesco said as a result of stronger-than-expected sales to date, it now expects retail operating profit for financial 2022 slightly above the top-end of its previous GBP2.5 billion to GBP2.6 billion guidance range. It posted retail operating profit of GBP1.99 billion in financial 2021. "Despite growing cost pressures and supply chain challenges in the industry, we continued to invest to protect availability, doubled down on our commitment to deliver great value and offered our strongest ever festive range. This put us in a strong position to meet customers' needs as, once again, Covid-19 led to a greater focus on celebrating at home. As a result, we outperformed the market, growing market share and strengthening our value position," said Chief Executive Officer Ken Murphy.

----------

Housebuilder Persimmon hailed its "excellent" performance throughout 2021 and said the long-term fundamentals of the UK housing market remain strong. Persimmon said it delivered 14,551 new home completions in 2021, up from 13,575 in 2020, with an average selling price of GBP237,050, up from GBP230,534. The York-based housebuilder said total revenue in 2021 was GBP3.61 billion, up from GBP3.33 billion in 2020. New housing revenue was GBP3.45 billion, up from GBP3.13 billion. Addressing sector concerns, Persimmon said it agreed with the UK government that leaseholders should not have to pay to remove flammable cladding. Persimmon said it constructed only a "very small proportion" of buildings affected by this issue, which caused the deadly fire at the Grenfell Tower in 2017. In common with the rest of the housebuilding industry, it will shortly begin paying the cladding levy announced in the UK budget, it noted.

----------

In addition, Persimmon appointed Jason Windsor as its new chief financial officer, hired from insurer Aviva to succeed Mike Killoran, who will be retiring in mid-January. Aviva noted the announcement and said a search for a new CFO is underway.

----------

Pharmaceutical firm AstraZeneca has signed a collaboration agreement with Scorpion Therapeutics. Astra will pay Scorpion USD75 million upfront in cash and will have an exclusive over up to three drugs developed using the Scorpion drug discovery platform. The partnership will develop oncology treatments, focusing on hard-to-target cancer proteins. "The new collaboration focuses on a class of proteins called transcription factors, which control gene expression and can regulate important cellular processes including cell growth and survival," Astra explained. "Many transcription factors have long been identified as important targets for new cancer treatments and as drivers of disease, but have previously been considered 'undruggable' using conventional drug discovery approaches."

----------

COMPANIES - FTSE 250

----------

Food, clothing and homewares retailer Marks & Spencer said it put in a strong performance in its financial third quarter and over the Christmas period. For the 13 weeks to January 1, group sales were GBP3.27 billion, up 19% from the same time a year before. As a result of performance over the period, M&S said it was more confident of its ability to deliver the increased guidance it set, and now expects full-year profit before tax and adjusting items of at least GBP500 million. "Trading over the Christmas period has been strong, demonstrating the continued improvements we've made to product and value. Clothing & Home has delivered growth for the second successive quarter, supported by robust online and full price sales growth. Food has maintained its momentum, outperforming the market over both 12 and 24 months," said CEO Steve Rowe.

----------

COMPANIES - GLOBAL

----------

Crown Resorts said it has received a revised takeover proposal from US private equity firm Blackstone. The Australian gambling operator said the offer was AUD13.10 per Crown Resorts share in cash. This is a AUD0.60 increase compared to Blackstone's previous offer of AUD12.50 per share in cash received back in November and is the third offer by Blackstone. Blackstone's original offer was for AUD11.85 per share in cash. Crown shares closed up 8.8% to AUD12.65 in Sydney on Thursday. Blackstone already has a 10% stake in Crown Resorts, having bought the shares from Melco Resorts & Entertainment Ltd for AUD8.15 per share in April 2020.

----------

Thursday's shareholder meetings

Blue Prism Group PLC - GM re takeover by SS&C Technologies

Centrica PLC - GM re sale of Spirit Energy

JPMorgan Japanese Investment Trust PLC - AGM

Kefi Gold & Copper PLC - GM re share placing

Victoria PLC - GM re issue of preferred shares

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.